Case Study: Top 10 Pharma Company achieves greater patient engagement and improved data quality with Clario

Vaccine developer achieves cost-effective and streamlined transition to electronic data capture

Top 10 Pharma Company ran a Phase 4 post‑approval hemophilia study but faced unreliable, paper‑based activity and infusion diaries that increased participant burden and produced missing or inaccurate data. Clario provided an electronic data capture eDiary solution with Fitbit wearable integration, enabling patients to log bleeds, infusions and daily activity via their own smartphones or provisioned devices.

Clario’s app captured real‑time activity and clinical entries for 50 study participants, improving the consistency and quality of collected data, reducing missing and erroneous entries, and lowering burden on patients. Engagement features like two‑week data views, reminders and motivational messages helped retain participants and gave investigators faster access to richer real‑world data for the Top 10 Pharma Company.